Earnings / Life Sciences
Danaher Beats Third-Quarter Earnings Forecasts and Raises Its Profit Outlook as Core Growth Excluding Respiratory Testing Reaches 5.5%
Adjusted earnings of $2.11 a share topped the $1.92 consensus and revenue of $6.55 billion was essentially in line — but a $263 million discrete tax benefit, not operations, explains most of the reported profit line's 34.5% jump.